Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Viatris Pty Ltd
Administration route
Intramuscular injection
Subcutaneous injection
Vaccine group
All people aged ≥6 months
Description:
Registered for use in people aged ≥6 months.
Trivalent inactivated influenza vaccine, surface antigen.
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 3 recommended influenza virus strains
and not more than:
- 100 ng ovalbumin
- 0.01 mg formaldehyde
- 0.015 mg cetrimonium bromide
- 1 mg sodium citrate
- 0.2 mg sucrose
- 1 ng gentamicin sulfate
May contain traces of:
- chicken proteins
- tylosine tartrate
- polysorbate 80
- hydrocortisone
For Product Information and Consumer Medicine Information about Influvac visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases